Boschi, C.; Scheim, D.E.; Bancod, A.; Militello, M.; Bideau, M.L.; Colson, P.; Fantini, J.; Scola, B.L.
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. Int. J. Mol. Sci. 2022, 23, 15480.
https://doi.org/10.3390/ijms232415480
AMA Style
Boschi C, Scheim DE, Bancod A, Militello M, Bideau ML, Colson P, Fantini J, Scola BL.
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. International Journal of Molecular Sciences. 2022; 23(24):15480.
https://doi.org/10.3390/ijms232415480
Chicago/Turabian Style
Boschi, Celine, David E. Scheim, Audrey Bancod, Muriel Militello, Marion Le Bideau, Philippe Colson, Jacques Fantini, and Bernard La Scola.
2022. "SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects" International Journal of Molecular Sciences 23, no. 24: 15480.
https://doi.org/10.3390/ijms232415480
APA Style
Boschi, C., Scheim, D. E., Bancod, A., Militello, M., Bideau, M. L., Colson, P., Fantini, J., & Scola, B. L.
(2022). SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. International Journal of Molecular Sciences, 23(24), 15480.
https://doi.org/10.3390/ijms232415480